Giving Voice to Canadians Concerned About Breast Cancer

ACTION

Get Involved

Invitation to Participate in Study of Preferences for Advanced Breast Cancer Treatments in Canada

We would like to invite you to participate in a study regarding preferences for treatment of advanced breast cancer in Canada.  The study is sponsored by Novartis. The information from this study may be included in research publications and submissions to agencies that evaluate and make recommendations regarding reimbursement of treatments for patients in Canada.

In order to qualify for participation, you must (1) be female, (2) be at least 18 years old, (3) currently reside in Canada, and (4) have a current diagnosis of metastatic or advanced breast cancer (Stage III or IV).

The study will require approximately 15 minutes to complete. Your responses will be anonymous and confidential. There is no risk associated with taking part in this study. You will not be paid for participating in this study.

Participation in this research is voluntary.  If you choose to begin the study, you may withdraw at any time.

PAI, the organization conducting the study, has received consulting fees from Novartis Pharmaceuticals Canada, and the study principal investigator is a partner at PAI.

To participate in this study, please click the link below. The study will remain open for completion until midnight (EST) on Friday, July 5, 2019.

https://BCPatientCanada.sawtoothsoftware.com/login.html  

If you have any questions, you may contact the study manager or the sponsor directly using the contact information below. Advarra IRB reviewed this study to help ensure that your rights and welfare are protected and that this study is carried out in an ethical manner. If you would like to contact them about your rights as a research participant, their email address is adviser@advarra.com and the toll free number is 877-992-4724. Please reference the following number when contacting the Study Subject Adviser: Pro00033833.

Study Manager:

Daniel Stellato, BS
Research Analyst
Policy Analysis Inc. (PAI)
Four Davis Court
Brookline, MA 02445
USA
Phone: 617-232-4400
Email: dstellato@pai2.com

Study Sponsor:

Novartis Pharmaceuticals
Oncology Business Unit
Novartis Pharmaceuticals
385 Bouchard Blvd.
Dorval, Quebec H9S 1A9
CANADA
Phone: 514-631-6775

About Policy Analysis Inc. (PAI)

PAI is a health economics and outcomes research (HEOR) organization providing services to the global biopharmaceutical industry located in Brookline, Massachusetts, USA (https://www.pai2.com).

About Novartis

Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide (https://www.novartis.ca/en).

SHARE

Financial
Navigator

Your path to accessing financial resources

Quick Find

Our Stories

Events

See our calendar